Limitations of genomic surveillance: a C. difficile case study in the Netherlands [0.03%]
基因组监测的局限性：来自荷兰的一例艰难梭菌研究
Joffrey van Prehn,Simone Abma Blatter,Sylvia Debast et al.
Joffrey van Prehn et al.
Re: 'Systematic investigation of baseline nosocomial transmission of tuberculosis in the Kyrgyz Republic, Central Asia' by Hoffmann et al [0.03%]
关于霍夫曼等人发表的《中亚吉尔吉斯共和国医院内结核基线传播的系统调查》的评论
Charlotte Genestet,Elisabeth Hodille,Claire Merveilleux du Vignaux et al.
Charlotte Genestet et al.
Screening for antibiotics residues among adults with respiratory infections in primary care in Switzerland: evaluating over-the-counter use and environmental exposure [0.03%]
在瑞士初级保健中筛查呼吸道感染成人患者的抗生素残留物：评估非处方药使用和环境暴露的影响
Noémie Wäfler,José Knüsli,Loïc Lhopitallier et al.
Noémie Wäfler et al.
Acquired Resistance during Short-Course Treatment for Rifampicin-Resistant Tuberculosis [0.03%]
利福平耐药结核病短程化疗中的获得性耐药性
Xinchang Chen,Cui Cai,Lingyun Song et al.
Xinchang Chen et al.
Background: Shorter regimens represent a significant advancement for rifampicin-resistant tuberculosis (RR-TB) treatment. However, data on acquired drug resistance (ADR) remain limited. ...
Esther Vaugon,Jennifer Dien Bard
Esther Vaugon
The WHO bacterial meningitis guideline and primum non nocere: Inaction may also lead to harm [0.03%]
世卫组织细菌性脑膜炎指南与首先要做的是不伤害：不作为也可能导致伤害
Jacob Bodilsen,Henrik Nielsen
Jacob Bodilsen
Hybrid Effectiveness-Implementation Studies in Infection Prevention and Infectious Diseases: A Narrative Review [0.03%]
感染预防和传染病中混合效果实施研究的叙事性综述
Lauren Clack,Marie-Therese Schultes,Bianca Albers et al.
Lauren Clack et al.
Background: Hybrid effectiveness-implementation studies simultaneously assess clinical effectiveness and implementation, thereby accelerating the translation of research into healthcare practice. Such designs are relevant...
An Overlooked Pathway of Indoor Air Toxicity and a Challenge to Current Paradigms of Sampling Methods [0.03%]
被忽视的室内空气毒性途径及对当前采样方法范式的挑战
Kirsi Vaali,Rudolf Krska,Panu Harmo et al.
Kirsi Vaali et al.
Laboratory innovations to diagnose invasive mould infections - what is relevant, what is not? [0.03%]
实验室创新在侵袭性霉菌感染诊断中的应用——哪些有意义，哪些无意义？
Yuri Vanbiervliet,Robina Aerts,Lenn Maessen et al.
Yuri Vanbiervliet et al.
Background: Invasive mould infections (IMI) carry high morbidity and mortality. Conventional diagnostics - histopathology, culture and microscopy - rely on invasive sampling and lack sensitivity, particularly during early...
The changing epidemiology of invasive mold diseases in immunosuppressed patients: what, why, how? [0.03%]
免疫抑制患者的侵袭性霉菌病的流行病学变化：什么、为什么、如何？
Anna Apostolopoulou,Eleftheria Kampouri,Jessica S Little
Anna Apostolopoulou
Background: The epidemiology of invasive mold diseases in immunocompromised hosts is evolving due to a combination of environmental and host-related factors. ...